Mohamed I. Elsaid

1. Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes
   2024/03/27 by Mohamed I. Elsaid, Na Li, Stephen A. Firkins +6 · 4 citations
   Medicine · #Diabetes Treatment and Management #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation